LinkedInFacebookFind us on youtubeTwitter
Free Monthly Newsletters click here to sign up     click here to sign up

sboy le321

sboyle321 at sboyle321

Biography

??????? ????? ????? ?????? Once in a while it really hits people that they don

Articles

Articles

Debraj Dasgupta, Head of Specialty Commercialization and Adherence at Novartis and Meike Wenzel, Associate Partner at Executive Insight examine the big questions surrounding the 'Beyond the Pill' movement and offer up a few solutions...
(Mar 8, 2013)
Debraj Dasgupta, Head of Specialty Commercialization and Adherence at Novartis and Meike Wenzel, Associate Partner at Executive Insight examine the big questions surrounding the 'Beyond the Pill' movement and offer up a few solutions...
(Mar 8, 2013)
Without educational support in their evolving role, physicians will be unable to advise their patients, and those patients will look elsewhere for information.
(Feb 28, 2013)
Without educational support in their evolving role, physicians will be unable to advise their patients, and those patients will look elsewhere for information.
(Feb 28, 2013)
With a stark change in public policy, the French healthcare system is facing a major overhaul. At stake is the relationship between big pharma and the French administration.
(Jul 19, 2012)
With a stark change in public policy, the French healthcare system is facing a major overhaul. At stake is the relationship between big pharma and the French administration.
(Jul 19, 2012)
In a new wave of innovations, yesterday, 20,000 jobs were innovated in R&D at Beezer Pharmaceuticals.
(Nov 29, 2011)
Yesterday, perfect balance was found, a state of sublime poise between the efficacy and safety of bolloxizumab.
(Nov 8, 2011)
As patients increasingly drive their own medical care, the value of direct, two-way conversation between biopharma and patients also increases.
(Jul 11, 2011)
If you think your mission is value communication, think again
(May 17, 2011)